Jiangsu Jibeier Pharmaceutical Co., Ltd. (SHA:688566)

Market Cap	6.42B +40.2%
Revenue (ttm)	964.93M +7.6%
Net Income	258.67M +17.9%
EPS	1.30 +15.0%
Shares Out	199.43M
PE Ratio	24.75
Forward PE	n/a
Dividend	0.78 (2.42%)
Ex-Dividend Date	n/a

Volume	4,182,888
Average Volume	3,848,012
Open	31.88
Previous Close	32.18
Day's Range	31.50 - 32.92
52-Week Range	20.77 - 44.68
Beta	0.52
RSI	63.79
Earnings Date	Apr 28, 2026

About SHA:688566

Jiangsu Jibeier Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the drug research and development and production in China. The company’s products cover multiple therapeutic areas such as increasing white blood cells, fighting hypertension, enhancing immunity, treating joint diseases, fighting eye infections, treating bronchitis, protecting liver function, etc. It is also developing drugs for the treatment of depression, tumors, stomach and gastric diseases, and other diseases. In addition, the company offers its products in table...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 1,326
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688566

Financial Performance

In 2025, SHA:688566's revenue was 964.93 million, an increase of 7.63% compared to the previous year's 896.53 million. Earnings were 258.67 million, an increase of 17.94%.